OrganiGram (TSX:OGI), (NASDAQ:OGI) is a Canadian company specializing in the production and sale of high-quality, medical and recreational cannabis. The brand is well-known for its focus on innovation, quality control, and patient and customer care. OrganiGram operates out of Moncton, New Brunswick, where it runs a state-of-the-art indoor facility designed to produce consistent, high-quality cannabis. The company is involved in various projects aimed at cannabis product development, including advanced genetics research, novel cultivation techniques, and the creation of new product formulations. OrganiGram's objectives center around expanding its market share in Canada, exploring international markets, and continuing to innovate within the cannabis industry to meet the evolving needs and preferences of its customers.